Announcing Chinese Journal of Cancer's first Impact Factor

Editor-in-Chief: Yi-Xin Zeng (China)

Submit a manuscript

Editorial Board

Author Instructions

Article Alerts

Dear Prof CERASALE MORTEO,

We are very pleased to announce that the open access journal Chinese Journal of Cancerhas received its first Impact Factor of 2.16.

Read these influential articles and submit your next manuscript to the journal.

Influential Articles:

Cancer research in the era of next-generation sequencing and big data calls for intelligent modelling

Cytokine-induced killer (CIK) cells: from basic research to clinical translation

ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel

Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin’s lymphoma: evidence from a meta-analysis

Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization

The Benefits of Publishing with Us:

	High quality peer-review service
	Expert Editorial Board
	Rapid publication upon acceptance
	Widest possible global dissemination of your research
	Inclusion in a number of relevant full-text repositories

Please forward this email and share the good news.

Kind regards,

The BioMed Central Team